The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,555
Sort by:
The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023
US$ 3,000.00
... reach $143.7bn by 2023. GMR Data’s latest report 'The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023’ explains just how ... Within GMR Data’s 'The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023’ we analyse the key cancer drugs and treatments in the market currently and ...
November 2013
243 pages
2014 Nucleic Acid Testing Market: Strategic Assessments of Leading Strategic Suppliers
US$ 2,800.00
This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as ... assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, ...
November 2013
549 pages
Research Report on China Osteoporosis Drug Market, 2013-2017
US$ 1,800.00
... vitamin D and analogues, and calcitonins always took up above 98% shares of China osteoporosis drug market. The market share of bisphosphonates increased at the ... global pharmaceutical enterprises, they will find huge market opportunities in China. Through this report, the readers can acquire the following ...
November 2013
30 pages
2014 Analysis of the Global Drugs of Abuse Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... (test volumes, sales forecasts, supplier shares) $5,500. This new 318-page report from Venture Planning Group contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic ...
November 2013
318 pages
2014 Analysis of the UK Drugs of Abuse Testing Market: Hospitals and Commercial Labs
US$ 1,960.00
This new 260-page report from Venture Planning Group provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2013
260 pages
2014 Analysis of the European Drugs of Abuse Testing Market: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
This new 300-page report from Venture Planning Group provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2013
300 pages
2014 Analysis of the Global Therapeutic Drug Monitoring (TDM) Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... volumes, sales forecasts, supplier shares) $5,500. This new 313-page report from Venture Planning Group contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and ...
November 2013
313 pages
2014 Analysis of the European Therapeutic Drug Monitoring (TDM) Market : Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers
US$ 5,200.00
This new 291-page report from Venture Planning Group provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and ...
November 2013
291 pages
US Lung Cancer Drug Pipeline Analysis
US$ 1,800.00
... annual statistics published, an estimated 201,144 people in the United States were diagnosed with lung cancer. This figure included 107,164 men and ... drug market based upon development process. Following parameters for each drug profile in development phase are covered in “US Lung Cancer Drug Pipeline Analysis ...
November 2013
385 pages
US Colorectal Cancer Drug Pipeline Analysis
US$ 1,500.00
... that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions ... market based upon development process. Following parameters for each drug profile in development phase are covered in “US Colorectal Cancer Drug Pipeline ...
November 2013
242 pages
US Parkinson's Disease Drug Pipeline Analysis
US$ 1,500.00
... in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. ... drug market based upon development process. Following parameters for each drug profile in development phase are covered in “US Parkinson’s Disease Drug Pipeline Analysis ...
November 2013
241 pages
Global RNAi Drug Pipeline Analysis
US$ 1,500.00
... location. “Global RNAi Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed based upon RNAi technology. ... Drug market based upon development process. Following parameters for each drug profile in development phase are covered in “Global RNAi Drug Pipeline ...
October 2013
250 pages
US Orphan Drug Pipeline Analysis
US$ 1,800.00
... from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the ... increasing, thus increasing the profit margins in the future. “US Orphan Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ...
October 2013
880 pages
Global Infertility Drug Pipeline Analysis
US$ 1,000.00
... drugs and treatment. The most lucrative markets for infertility drugs are the emerging nations such as India, Brazil, China and Mexico, ... pool of people being affected by lifestyle diseases, thus leading to infertility. “Global Infertility Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the ...
October 2013
60 pages
Orphan Drugs for Cancer Pipeline Analysis
US$ 1,800.00
... patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group ... drug profile in development phase are covered in “Orphan Drugs for Cancer Pipeline Analysis” research report: Drug Profile Overview Alternate Names for Drug ...
October 2013
855 pages
Global HIV Infection Drug Pipeline Analysis
US$ 1,500.00
... to identify and analyze the available investment opportunity in the HIV Infection drug market based upon development process. Following parameters for each drug profile in clinical development phase are covered in “Global HIV Infection Drug Pipeline Analysis” research report: Drug ...
October 2013
300 pages
US Alzheimer Drug Pipeline Analysis
US$ 2,000.00
... observed that almost 1 in 8 people coming under the 65+ age group are patients of Alzeimer’s disease. Amongst the population in the 80+ age group, almost ... market based upon development process. Following parameters for each drug profile in development phase are covered in “US Alzheimer Drug Pipeline Analysis” ...
October 2013
348 pages
US Prostate Cancer Drug Pipeline Analysis
US$ 1,800.00
... Clinical Trial Owner / Originator/ Licensee/Collaborator Administrative Route Drug Class ATC Codes US Prostate Cancer Drug Pipeline by Clinical Phase: Research: 11 Preclinical: 44 Unknown Phase: 4 Phase 0: 1 Phase-I: 22 Phase-I/II: 18 Phase-II: 53 Phase-II/III: 1 Phase-III:14 Marketed: 13
October 2013
375 pages
US Breast Cancer Drug Pipeline Analysis
US$ 1,800.00
... and new therapies would account for more than 25% of the overall market for breast cancer drug treatments. “US Breast Cancer Drug Pipeline Analysis” by ... drug market based upon development process. Following parameters for each drug profile in development phase are covered in “US Breast Cancer Drug Pipeline ...
October 2013
480 pages
Europe Breast Cancer Drug Pipeline Analysis
US$ 1,800.00
... opportunity in the Breast Cancer drug market based upon development process. Following parameters for each drug profile in development phase are covered in “Europe Breast Cancer Drug Pipeline Analysis” research report: Drug Profile Overview Alternate Names ...
October 2013
380 pages
Emergency Contraception in the Netherlands
US$ 990.00
... low in the Netherlands, perhaps explained by the relatively low level of unwanted pregnancies amongst the young population. Euromonitor International's Emergency Contraception in Netherlands report offers ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
September 2013
23 pages
Gene Therapy Drug Pipeline Analysis
US$ 1,500.00
... in development phase enables the reader to identify and understand the Gene Therapy associated with the various diseases. This report enables pharmaceutical ... parameters for each drug profile in development phase are covered in “Gene Therapy Drug Pipeline Analysis” research report: Drug Profile Overview ...
September 2013
185 pages
Drug Injection Devices to 2018
US$ 4,850.00
... is pleased to announce the publication of a new market study. Drug Injection Devices to 2018: Devices, Markets, Strategies and Forecasts is a comprehensive evaluation and ... benefit from this study. The Proliferation and Penetration of New Injection Device Technology The past decade has seen a dramatic shift ...
August 2013
265 pages
Emergency Contraception in South Africa
US$ 990.00
... afford to buy emergency contraceptive pills if they happen to have unprotected sexual intercourse. Emergency contraceptive pills are relatively expensive for an average person in South Africa, as the unit price averages around R44 for a single tablet. Growth in value sales for contraceptive pills in South Africa is... Euromonitor International's Emergency Contraception in South Africa report ...
August 2013
20 pages
Emergency Contraception in Portugal
US$ 990.00
... also impacted on sales of emergency contraception. Due to their precarious financial situation, many couples have no choice... Euromonitor International's Emergency Contraception in Portugal report offers a comprehensive guide ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
August 2013
21 pages
Calming and Sleeping in Iran
US$ 990.00
Calming and sleeping is a relatively new OTC category in Iran. There is wide range of domestic and imported brands in the category, ... for sleeping aids. While OTC sales of synthetic calming and sleeping products are not permitted under the regulations of the... Euromonitor International's Calming and Sleeping in Iran ...
August 2013
16 pages
Emergency Contraception in Belgium
US$ 990.00
... young, are still studying or do not want children. Euromonitor International's Emergency Contraception in Belgium report offers a comprehensive guide to the size and shape of the ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
August 2013
30 pages
Emergency Contraception in Austria
US$ 990.00
... . Emergency contraception was strongly influenced by this in 2012. In addition, the performance of the category was influenced by the fact that the first ever emergency contraception brand was introduced only in January 2010 in Austria, which still leaves a great deal of room... Euromonitor International's Emergency Contraception in Austria report offers ...
August 2013
21 pages
Emergency Contraception in Switzerland
US$ 990.00
The availability of OTC emergency contraception in Switzerland, as well as the more liberal attitudes of Swiss youngsters, drove sales of emergency contraception over the review period. Emergency contraception is mainly used by young women, many of whom do not have access to information about preventative birth control methods. Euromonitor International's Emergency Contraception in Switzerland report ...
August 2013
25 pages
Calming and Sleeping in Kenya
US$ 990.00
... hectic lifestyles, stress and stress-induced insomnia. Euromonitor International's Calming and Sleeping in Kenya report offers a comprehensive guide to the size and shape ... . Why buy this report? Get a detailed picture of the Calming and Sleeping market; Pinpoint growth sectors and identify factors driving change ...
August 2013
15 pages
Calming and Sleeping in Cameroon
US$ 990.00
... value sales of calming and sleeping products in Cameroon were up by 5% in 2012. Demand grew mostly due to population growth and a rise in urbanisation. In Cameroon these products are ... by stress among upper- and middle-income consumers. Euromonitor International's Calming and Sleeping in Cameroon report offers a comprehensive guide to the size and shape ...
August 2013
16 pages
Emergency Contraception in Cameroon
US$ 990.00
... hold the view that the product is abortive. Euromonitor International's Emergency Contraception in Cameroon report offers a comprehensive guide to the size and shape of the ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
August 2013
15 pages
Malaria Disease Drug Pipeline Analysis
US$ 1,200.00
... purchasing Hard Copy License depending on the location. “Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ... on the development process. Insight for each drug profile in development phase enables the reader to identify and understand the therapeutics associated ...
August 2013
185 pages
Emergency Contraception in New Zealand
US$ 990.00
Emergency contraception continued to be an acceptable medical method of preventing pregnancy within New Zealand during 2012. While abortion services are provided for free within New Zealand for ... disagreement, however, in general there is a high level of approval of emergency contraception products in... Euromonitor International's Emergency Contraception in New Zealand report offers a comprehensive guide to the size and shape ...
July 2013
28 pages
OTC Triptans in New Zealand
US$ 990.00
During 2012 there were only two OTC triptan products available in New Zealand, Sumagran Active (Mylan New Zealand) and Zomig (AstraZeneca). Several other prescription products ... -Sumatriptan, however only the latter was subsidised. Euromonitor International's OTC Triptans in New Zealand report offers a comprehensive guide to the size and shape of the ...
July 2013
31 pages
Emergency Contraception in Bulgaria
US$ 990.00
... the product, but also created awareness of emergency contraception products, and their usage... Euromonitor International's Emergency Contraception in Bulgaria report offers a comprehensive guide to the size ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
July 2013
17 pages
Emergency Contraception in the United Kingdom
US$ 990.00
... 2012, emergency contraception increased by 3% in current value terms, to reach £25 million. After the introduction of OTC emergency contraceptive pills in 2001, growth was initially rapid, as women chose the option of convenience, and purchased in a pharmacy. Euromonitor International's Emergency Contraception in United Kingdom report ...
July 2013
29 pages
